Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.

Merani S, Pawelec G, Kuchel GA, McElhaney JE.

Front Immunol. 2017 Jul 17;8:784. doi: 10.3389/fimmu.2017.00784. eCollection 2017. Review.

2.

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.

Khairallah C, Déchanet-Merville J, Capone M.

Front Immunol. 2017 Feb 9;8:105. doi: 10.3389/fimmu.2017.00105. eCollection 2017. Review.

3.

The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Hornig J, Choi KY, McGregor A.

Virology. 2017 Apr;504:122-140. doi: 10.1016/j.virol.2017.01.023. Epub 2017 Feb 10.

PMID:
28189970
4.

Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.

Chen SF, Holmes TH, Slifer T, Ramachandran V, Mackey S, Hebson C, Arvin AM, Lewis DB, Dekker CL.

J Pediatric Infect Dis Soc. 2016 Mar;5(1):14-20. doi: 10.1093/jpids/piu089. Epub 2014 Sep 11.

5.

Limits and patterns of cytomegalovirus genomic diversity in humans.

Renzette N, Pokalyuk C, Gibson L, Bhattacharjee B, Schleiss MR, Hamprecht K, Yamamoto AY, Mussi-Pinhata MM, Britt WJ, Jensen JD, Kowalik TF.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4120-8. doi: 10.1073/pnas.1501880112. Epub 2015 Jul 6.

6.

Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Gibson L, Barysauskas CM, McManus M, Dooley S, Lilleri D, Fisher D, Srivastava T, Diamond DJ, Luzuriaga K.

J Clin Immunol. 2015 Apr;35(3):289-301. doi: 10.1007/s10875-015-0139-3. Epub 2015 Feb 25.

7.

Immunity to cytomegalovirus in early life.

Huygens A, Dauby N, Vermijlen D, Marchant A.

Front Immunol. 2014 Oct 30;5:552. doi: 10.3389/fimmu.2014.00552. eCollection 2014. Review.

8.

Development of a novel, guinea pig-specific IFN-γ ELISPOT assay and characterization of guinea pig cytomegalovirus GP83-specific cellular immune responses following immunization with a modified vaccinia virus Ankara (MVA)-vectored GP83 vaccine.

Gillis PA, Hernandez-Alvarado N, Gnanandarajah JS, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2014 Jun 30;32(31):3963-70. doi: 10.1016/j.vaccine.2014.05.011. Epub 2014 May 20.

9.

DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

Gil A, Shen S, Coley S, Gibson L, Diamond DJ, Wang S, Lu S.

Hum Vaccin Immunother. 2013 Oct;9(10):2120-32. doi: 10.4161/hv.25750. Epub 2013 Jul 25.

10.

Genetic analysis of cytomegalovirus in malignant gliomas.

Bhattacharjee B, Renzette N, Kowalik TF.

J Virol. 2012 Jun;86(12):6815-24. doi: 10.1128/JVI.00015-12. Epub 2012 Apr 11.

11.

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.

Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.

J Infect Dis. 2011 Dec 1;204(11):1663-71. doi: 10.1093/infdis/jir624. Epub 2011 Oct 21.

12.

Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants.

Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF.

PLoS Pathog. 2011 May;7(5):e1001344. doi: 10.1371/journal.ppat.1001344. Epub 2011 May 19.

13.

Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.

Abel K, Martinez J, Yue Y, Lacey SF, Wang Z, Strelow L, Dasgupta A, Li Z, Schmidt KA, Oxford KL, Assaf B, Longmate JA, Diamond DJ, Barry PA.

J Virol. 2011 Mar;85(6):2878-90. doi: 10.1128/JVI.00883-10. Epub 2010 Dec 29.

14.

Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.

Lim JB, Kim HO, Jeong SH, Ha JE, Jang S, Lee SG, Lee K, Stroncek D.

J Transl Med. 2009 Aug 23;7:72. doi: 10.1186/1479-5876-7-72.

15.

Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Cheeran MC, Lokensgard JR, Schleiss MR.

Clin Microbiol Rev. 2009 Jan;22(1):99-126, Table of Contents. doi: 10.1128/CMR.00023-08. Review.

16.

Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.

Bao L, Dunham K, Stamer M, Mulieri KM, Lucas KG.

Biol Blood Marrow Transplant. 2008 Oct;14(10):1156-62. doi: 10.1016/j.bbmt.2008.07.014.

17.

Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues.

Wilhelmi V, Simon CO, Podlech J, Böhm V, Däubner T, Emde S, Strand D, Renzaho A, Lemmermann NA, Seckert CK, Reddehase MJ, Grzimek NK.

J Virol. 2008 Oct;82(20):9900-16. doi: 10.1128/JVI.00928-08. Epub 2008 Aug 6.

18.

CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.

Bantug GR, Cekinovic D, Bradford R, Koontz T, Jonjic S, Britt WJ.

J Immunol. 2008 Aug 1;181(3):2111-23.

19.

Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.

Pipeling MR, West EE, Osborne CM, Whitlock AB, Dropulic LK, Willett MH, Forman M, Valsamakis A, Orens JB, Moller DR, Lechtzin N, Migueles SA, Connors M, McDyer JF.

J Immunol. 2008 Jul 1;181(1):546-56.

20.

Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment.

Currier JR, Galley LM, Wenschuh H, Morafo V, Ratto-Kim S, Gray CM, Maboko L, Hoelscher M, Marovich MA, Cox JH.

Clin Vaccine Immunol. 2008 Feb;15(2):267-76. Epub 2007 Dec 12.

Supplemental Content

Support Center